Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: RTO=Reverse Take Over

Regarding any reverse merger. Who owns the other 50% of the MMP patents? TPL or More? If it is More, then I suggest that perhaps it is really all up to Chuck More.

And I would think Chuck would like to see MMP unified. But first PTSC must clean up its books and eliminate Swartz from the picture. Then Intellasys reverse merges with PTSC retaining Intellasys CEO. TPL remains private collecting a large upfront sum and retaining an interest in the newly merged company which then changes name and ticker. Well that's the way I hope he sees the future. Opty

Share
New Message
Please login to post a reply